Relay Therapeutics, Inc.
RLAY
$19.86
-$0.07-0.35%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -83.71M | -73.29M | -54.89M | -74.15M | -70.38M |
| Total Depreciation and Amortization | 360.00K | 504.00K | 599.00K | 748.00K | 1.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.56M | 9.76M | 12.25M | 14.78M | 16.02M |
| Change in Net Operating Assets | 20.68M | 11.92M | -2.82M | -3.50M | -1.91M |
| Cash from Operations | -54.11M | -51.11M | -44.87M | -62.12M | -55.26M |
| Capital Expenditure | -- | -- | -1.00K | 1.00K | -26.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -353.03M | 32.90M | 35.46M | 39.72M | 75.17M |
| Cash from Investing | -353.03M | 32.90M | 35.46M | 39.73M | 75.15M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 323.74M | 138.78M | 934.00K | 17.00K | 653.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 323.74M | 138.78M | 934.00K | 17.00K | 653.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -83.40M | 120.57M | -8.47M | -22.38M | 20.54M |